Chennai-based Global Pharma Healthcare in radar for exporting contaminated eye drops
The company has exported two consignments of 24 batches of ‘Artificial Tears’ to the US which were manufactured in 2021 and 2022<br />
Quality / GMP | 06/02/2023 | By Sudeep Soparkar | 1031
US FDA completes inspection of Natco's Vizag formulation facility
The facility received two observations, one on the written production process control procedure and the other on the investigation procedure
Quality / GMP | 06/02/2023 | By Sudeep Soparkar | 1333
US FDA concludes inspection of Gland Pharma's Visakhapatnam facility with zero observations
The inspection was conducted at the company's API Facility at JNPC, Visakhapatnam, from January 23 to 27, 2023
Quality / GMP | 30/01/2023 | By Sudeep Soparkar | 917
US FDA places Glenmark Pharma's Baddi facility under import alert
The company will engage with the agency to resolve the import alert at the earliest
Quality / GMP | 27/01/2023 | By Sudeep Soparkar | 1122
Solara Active Pharma Sciences' Cuddalore facility completes WHO PQ inspection
The Cuddalore API site is a multi-product facility
<br />
Quality / GMP | 27/01/2023 | By Sudeep Soparkar | 1559
Torrent Pharma gets US FDA warning letter for Gujarat facility
The company said that this inspection classification will not have an impact on existing supplies or revenues from this facility
Quality / GMP | 25/01/2023 | By Sudeep Soparkar | 1381
US FDA inspects Indoco Remedies' solid oral formulation facility in Goa
The inspection was conducted from January 16 to 20, 2023
Quality / GMP | 24/01/2023 | By Sudeep Soparkar | 621
Strides Pharma completes WHO PQ inspection at Puducherry facility
The inspection was carried out between January 16-20, 2023
Quality / GMP | 23/01/2023 | By Sudeep Soparkar | 1120
Stelis Biopharma's facility receives EIR from US FDA
The company received the EIR from USFDA for the drug-device combination to be commercialised from the company's flagship facility in Bengaluru<br />
Quality / GMP | 20/01/2023 | By Sudeep Soparkar | 1093
Switzerland, US in agreement on pharma GMP
Under the agreement, both countries will be able to utilise each other’s GMP inspections of pharmaceutical manufacturing facilities, avoiding the need for duplicate inspections
Quality / GMP | 19/01/2023 | By Sudeep Soparkar | 837
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy